Hydrogen Therapy May Improve Lung Transplant Success Rates
Letter to the Editor on 'Profiling molecular changes induced by hydrogen treatment of lung allografts prior to procurement'
Research hubs: Respiratory System · Cardiovascular System
- Evidence type
- Review or commentary
- Authors
- Jing Yao Zhang, Chang Liu
- Journal
- Biochemical and Biophysical Research Communications
- Year
- 2012
- PMID
- 22995313
- Study Type
- clinical
- Peer Reviewed
- Yes
- Cited by
- 0 (OpenAlex, as of November 2026)
- Country
- China
TL;DR
Scientists found that treating donated lungs with hydrogen gas before transplant might help prevent damage that happens when blood flow is cut off and then restored, which could make the transplanted lungs work better after surgery.
Summary
This research letter discusses the potential of hydrogen therapy to enhance lung transplant procedures. Scientists investigated how treating donor lungs with hydrogen during the procurement phase could modify molecular pathways and reduce damage. The study suggests hydrogen therapy may help protect organs from ischemia-reperfusion injury, which occurs when blood flow is restored to transplanted organs. By reducing this type of damage, hydrogen treatment could improve the quality of donor lungs and potentially increase transplant success rates. While this is editorial correspondence without detailed study results, it highlights hydrogen's promising role in organ preservation and transplant medicine.